ipilimumab N01

Advertisement

cGxPJobs Banner

Innovent Secures NMPA Approval for TABOSUN in Colon Cancer

SAN FRANCISCO, U.S. & SUZHOU, China | December 25, 2025 — Innovent Biologics announced that TABOSUN® (ipilimumab N01 injection),...

By cGxPwire Editor
December 26, 2025

Read More

Advertisement

cGxPJobs

Directory